Combined DMT–harmine formulation reduces negative self-referential emotions during social self-evaluation: a randomized placebo-controlled trial in healthy volunteers
A new study examined whether a pharmaceutical formulation inspired by ayahuasca could reduce feelings of shame and embarrassment during socially evaluative situations
A new study examined whether a pharmaceutical formulation inspired by ayahuasca could reduce feelings of shame and embarrassment during socially evaluative situations
This was a Randomised, double-blind, placebo-controlled, crossover trial. 36 healthy men were recruited; 28 completed the full protocol and were included in the primary analyses.
Interventions:
Harmine (100 mg buccal) + DMT (100 mg intranasal, given as repeated 10 mg doses)
Harmine alone (100 mg)
Placebo
Each participant received all three interventions on separate study days
Key findings
Reduced embarrassment about oneself - Compared with placebo, the harmine + DMT combination significantly reduced embarrassment when participants listened to recordings of their own singing.
Reduced shame - The combined treatment significantly lowered:
overall shame scores
the emotional component of shame
Increased positive emotional responses
During self-listening, participants receiving harmine + DMT reported:
less unpleasantness
greater pleasantness
than under placebo, suggesting an acute shift towards more positive emotional processing of self-relevant experiences
Harmine alone showed little effect - Harmine without DMT did not significantly reduce embarrassment or shame.
The study provides early experimental evidence that an ayahuasca-inspired harmine + DMT formulation can acutely reduce embarrassment and emotional shame during socially evaluative situations in healthy men. Harmine alone produced no significant benefit. While the findings support further investigation into psychedelic-assisted treatments targeting excessive self-criticism and shame, they should not be interpreted as evidence of efficacy for psychiatric disorders until confirmed in larger clinical trials.
Abstract
Rationale and objectives
Negative self-referential emotions such as embarrassment and shame play a key role in the psychopathology of psychiatric disorders but are often insufficiently addressed by standard treatments. Psychedelics such as ayahuasca – an Amazonian plant decoction containing the psychedelic N,N-dimethyltryptamine (DMT) and harmala alkaloids, have been proposed to positively modulate self-referential processing. The aim of this study was to investigate the effects of an ayahuasca-inspired harmine+DMT formulation and harmine on embarrassment and shame.
Methods
In this randomized, double-blind, placebo-controlled crossover trial (N = 28 healthy males), the effects of combined 100mg harmine and 100mg DMT (HAR/DMT), harmine alone (HAR), against placebo (PLA) on self-referential processing was investigated using a karaoke paradigm, where participants listened to recordings of their own singing (Self = S) and control vocal tracks (other bad = OB; other good = OG) and rated emotional responses. Acute emotions were assessed with visual analogue scales (items: pleasant, unpleasant, embarrassing, funny, and objective quality) and the Experiential Shame Scale (ESS).
Results
HAR/DMT compared to placebo significantly reduced embarrassment in the Self condition (EMM=-16.83, p=.001), but not in the two other conditions (OB: EMM=-4.38, p=.628; OG: EMM= 2.14, p=.894). HAR/DMT–HAR or HAR–PLA contrasts for embarrassment were not significant for any condition. HAR/DMT compared to placebo reduced ESS global score (F(df)= 4.26(2, 54); p=.019) and ESS emotional subscale (F(df)=5.11(2, 54); p=.009), while harmine alone showed no significant effects.
Conclusions
These findings suggest that HAR/DMT acutely modulates negative self-referential emotions and may, thus, offer a promising therapeutic approach, which should be further investigated in clinical populations.
Aicher, H.D., Dornbierer, J., Caflisch, L. et al. Combined DMT–harmine formulation reduces negative self-referential emotions during social self-evaluation: a randomized placebo-controlled trial in healthy volunteers. Psychopharmacology (2026). Read Paper
For more psychedelic news and research, visit the psychedelic health professional network homepage.